期刊文献+

靶向S区和C区基因的M1GS RNA核酶共同抑制HBV的表达 被引量:2

Inhibition of HBV replication by M1GS RNA ribozymes targeting the S and C regions of the HBV genome
下载PDF
导出
摘要 目的:研究靶向HBVS区和C区基因的M1GSRNA核酶共同作用对HBV基因表达的影响.方法:选择HBVayw亚型S区基因294nt和C区基因2333nt为切割位点,以含有编码M1RNA的DNA序列的质粒pTK117为模板,通过PCR扩增得到M1GSRNA核酶的DNA模板,并将其克隆至真核表达载体pEGFP-C1得到重组质粒pEGFP-GSS和pEGFP-GSC.将2个重组质粒共转染HepG2.2.15细胞,转染后ELISA法测细胞培养液中的HBsAg和HBeAg,RT-PCR检测HBVmRNA.结果:成功构建了分别靶向HBVS区基因和C区基因的真核表达载体.共转染HepG2.2.15细胞后,HBsAg和HBeAg的表达分别被抑制了33.2%和39.1%,HBVCmRNA和SmRNA分别被抑制了32.5%和29.7%,而HepG2.2.15细胞的增殖无明显变化.结论:靶向HBVS区和C区基因的M1GSRNA核酶共同作用可特异性抑制HBVS区和C区基因的表达. AIM: To construct two MIGS RNA ribozymes targeting the S region and C region of the HBV genome, and evaluate their inhibitory effect on HBV gene expression. METHODS: A 294-nt in the S region and a 2333-nt in the C region of HBV genome were selected as sites of cleavage. DNA templates for site-specific MIGS RNA ribozymes targeting the HBV genome were constructed by polymerase chain reaction (PCR) using plasmid pTK117 as template. Then, the DNA templates were cloned into the eukaryotic expression vector pEGFP-C1. The recombinant vectors pEGFP-GSS and pEGFP-GSC were co-transfected into HepG2.2.15 cells. HBsAg and HBeAg proteins were detected by enzyme linked immunosorbent assay (ELISA) and their mRNA levels were analyzed by RTPCR. RESULTS: The two ribozymes effectively inhibited the secretion of HBsAg and HBeAg in HepG2.2.15 cells, by 33.2% and 39.1%, respectively. RT-PCR results showed that HBV S and C mRNAs were markedly decreased by 29.7% and 32.5%, respectively. Expression of MIGS RNA ribozyme had no effect on the proliferation of HepG2.2.15 cells. CONCLUSION: These results demonstrate that vectors with site-specific MIGS RNA ribozymes targeting the S and C regions of HBV can inhibit HBV replication specificity in vitro.
出处 《世界华人消化杂志》 CAS 北大核心 2007年第28期2990-2994,共5页 World Chinese Journal of Digestology
关键词 乙型肝炎病毒 核酶 核糖核酸酶P 基因治疗 逆转录聚合酶链式反应 酶联免疫吸附试验 Hepatitis B virus Ribozyme RNase P Gene therapy Reverse transcription polymerase chain reaction Enzyme linked immunosorbent assay
  • 相关文献

参考文献3

二级参考文献300

  • 1[1]http://www.who.int/csr/disease/hepatitis/HepatitisB_who cdscsrlyo2002_2.pdf
  • 2[2]Chen CJ,Yang HI,Su J,Jen CL,You SL,Lu SN,Huang GT,Iloeje UH.Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.JAMA 2006;295:65-73
  • 3[3]Weller Ⅳ,Carreno V,Fowler MJ,Monjardino J,Makinen D,Thomas HC,Sherlock S.Acyclovir inhibits hepatitis B virus replication in man.Lancet 1982; 1:273
  • 4[4]Schalm SW.Treatment of chronic hepatitis type virus B.Hepatogastroenterology 1984; 31:12-16
  • 5[5]Sherlock S,Thomas HC.Treatment of chronic hepatitis due to hepatitis B virus.Lancet 1985; 2:1343-1346
  • 6[6]Trepo C,Ouzan D,Fontanges T,Chevallier M,Chossegros P,Degos F,Chevallier P,Hantz O.Therapeutic activity of vidarabine in symptomatic chronic active hepatitis related to HBV.J Hepatol 1986; 3 Suppl 2:S97-S105
  • 7[7]Alexander GJ,Fagan EA,Hegarty JE,Rolando N,Guarner P,Eddleston AL,Williams R.A controlled trial of acyclovir in stable chronic HBsAg,HBeAg-positive carriers.J Hepatol 1986;3 Suppl 2:S123-S127
  • 8[8]Schalm SW.Treatment of chronic hepatitis B.Neth J Med 1994;44:103-109
  • 9[9]Hadziyannis SJ,Manesis EK,Papakonstantinou A.Oral ganciclovir treatment in chronic hepatitis B virus infection:a pilot study.J Hepatol 1999; 31:210-214
  • 10[10]Niederau C,Heintges T,Lange S,Goldmann G,Niederau CM,Mohr L,Haussinger D.Long-term follow-up of HBeAgpositive patients treated with interferon alfa for chronic hepatitis B.N Engl J Med 1996; 334:1422-1427

共引文献141

同被引文献2

  • 1Yong Chen,Guofeng Cheng,Ram I. Mahato. RNAi for Treating Hepatitis B Viral Infection[J] 2008,Pharmaceutical Research(1):72~86
  • 2Fang Jia,Yi-Zheng Zhang,Chang-Mei Liu. A retrovirus-based system to stably silence hepatitis B virus genes by RNA interference[J] 2006,Biotechnology Letters(20):1679~1685

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部